This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will fund the development of a novel passive, compliant ankle prosthetic device called the APTO-Ankle. The $293,514 award to Orthocare Innovations LLC, a prosthetic device company, will support the design, prototyping, bench testing, and clinical evaluation of this unpowered ankle prosthesis. The goal is to...
This Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) provides $392,482 to the University of Colorado Boulder to investigate the potential benefits of customized and biomimetic (nature-inspired) ankle-foot orthoses (AFOs) for improving walking function in healthy individuals and those post-stroke. The primary objectives are to develop an AFO emulator system that can effectively mimic both single and dual-stiffness passive AFOs, and then use...
This National Science Foundation (NSF) Small Business Technology Transfer (STTR) Phase I project aims to develop a novel prescription process for customizing prosthetic feet based on individual patient characteristics. The $274,975 award, granted on September 15, 2023, will enable the awardee, Little Room Innovations LLC, to create a system that utilizes adjustable prosthetic foot prototypes and optimization algorithms to determine optimal mechanical properties for each patient's customized...
This Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) provides $207,611 to the University of Delaware to investigate the potential benefits of customized and biomimetic (nature-inspired) ankle-foot orthoses (AFOs) for improving walking function in healthy individuals and those post-stroke. The key objectives are to develop an AFO emulator that can mimic the properties of both dual-stiffness and single-stiffness passive AFOs, and then use...
This $199,750 Project Grant was awarded by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) under the ACL National Institute on Disability, Independent Living, and Rehabilitation Research program (CFDA 93.433). The grant was awarded on September 1, 2024 to The University of Texas Rio Grande Valley, in partnership with Results Group LLC, to evaluate the effectiveness of novel exoskeleton footwear with an integrated spring footplate (Flyband...
This National Institute of Child Health and Human Development (NICHD) Small Business Innovation Research (SBIR) Phase I award provides $306,869 to Kate Allyn Prosthetic Research, LLC to develop a novel pediatric prosthetic foot-ankle system designed for children's active play and diverse activities. The goal is to create a prosthetic foot that can adapt to uneven terrain and provide the ankle range of motion needed for dynamic movements like hopscotch. The project team previously developed a...
This $720,000 project grant from the National Science Foundation's Division of Information and Intelligent Systems (CFDA 47.070 - Computer and Information Science and Engineering) will develop a novel robotic ankle-foot orthosis (exoskeleton) system to assist older adults' mobility and gait ability in real-world ambulation. The project at North Carolina State University aims to design and fabricate a compact, lightweight robotic ankle-foot orthosis to provide powered assistance and enhance ankle...
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $295,000 to Biodynamik, a for-profit organization, to develop a novel implantable system that leverages distraction osteogenesis as a treatment for diabetic foot ulcers (DFUs). The objectives of this Phase I SBIR project are to complete the design and development of a low-profile implantable transverse tibial transport device that can...
The National Science Foundation (NSF) awarded the University of Alabama a $549,546 Project Grant under the Partnerships for Innovation - Research Partnerships (PFI-RP) program (CFDA 47.084). The 3-year project (08/01/2023 - 07/31/2026) aims to develop an affordable, powered lower-limb prosthetic device that provides versatile multi-modal operation to significantly improve mobility and quality of life for amputees. Key innovations include a novel common-core-components knee-ankle prosthesis...
This Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) provides $232,230 to the Regents of the University of Michigan to develop and evaluate a novel ankle-foot orthosis (AFO) design that incorporates a cam-based transmission to improve functionality and customizability. The key products and services to be delivered under this grant include: Designing multiple versions of a cam-based...
THE DEVELOPMENT OF A BIMODAL WALKING-RUNNING PROSTHETIC FOOT - PROJECT SUMMARY / ABSTRACT OVER THE COURSE OF THIS TWO-YEAR PHASE II EFFORT, LIBERATING TECHNOLOGIES, INC. (LTI), ALONG WITH ITS COLLABORATORS AT FILLAUER COMPANIES AND HANGER CLINIC, WILL REFINE, EXPAND, AND TEST A BIMODAL WALKING-RUNNING FOOT THAT WOULD THEN BE POISED TO BECOME A VIABLE COMMERCIAL PRODUCT THAT CAN BE REIMBURSED UNDER THE EXISTING L-CODE REIMBURSEMENT STRUCTURE. THE GOAL OF THIS PROJECT IS TO CREATE A SINGLE FOOT THAT IS OPTIMIZED IN EACH MODE AND COMPARABLE TO A WALKING FOOT WHEN IN A WALKING MODE AND A RUNNING FOOT WHEN IN RUNNING MODE. THIS NOVEL FOOT WOULD PROVIDE LOWER LIMB AMPUTEES WHO DON'T CURRENTLY HAVE THE ACCESS TO RUNNING FEET DUE TO THE LACK OF INSURANCE COVERAGE, THE OPPORTUNITY TO PARTICIPATE IN RUNNING AND OTHER RUNNING-BASED ACTIVITIES (E.G. BASKETBALL, ETC.) TO INCREASE PHYSICAL FITNESS. IN DOING SO, THE CAESAR FOOT WOULD ALSO ALLOW FOR THE INCREASED SOCIAL PARTICIPATION AND THE PHYSICAL AND MENTAL HEALTH BENEFITS THAT ARE ASSOCIATED WITH THESE ACTIVITIES. IN ORDER TO ACHIEVE THIS GOAL, WE WILL PROGRESS AND REFINE THE BIMODAL FOOT TECHNOLOGY WITH THE ACHIEVEMENT OF THE FOLLOWING OBJECTIVES: (1) ITERATE AND OPTIMIZE THE DESIGN OF THE BIMODAL FOOT TO ACHIEVE A FULLY FUNCTIONAL PROTOTYPE READY FOR TESTING, (2) PERFORM VERIFICATION TESTING TO CONFIRM THE PROTOTYPE MEETS THE DESIGN CRITERIA, (3) VALIDATE THE PROTOTYPE IN A PILOT TAKE-HOME TRIAL AND ASSESS ITS IMPACT ON THE PHYSICAL ACTIVITY OF LOWER LIMB AMPUTEES, AND (4) START PREPARING FOR AN FDA SUBMISSION FOR THE CAESAR FOOT. THE OUTCOMES WILL BE DATA THAT VERIFY AND VALIDATE THE BIMODAL FOOT DEVICE IN THE LABORATORY AND IN THE REAL WORLD. THE PRODUCT WILL BE A HIGHLY ADVANCED, COMMERCIALLY VIABLE, VERIFIED, AND VALIDATED BIMODAL PROSTHETIC FOOT. THIS INNOVATIVE DESIGN ALLOWS US TO ADDRESS BOTH OF THE IDENTIFIED PRIMARY BARRIERS PREVENTING LLAS FROM TAKING PART IN THESE ACTIVITIES: 1) INADEQUATELY DESIGNED PROSTHESES (BY PROVIDING A FOOT WITH OPTIMIZED DESIGN, ALIGNMENT, AND BIOMECHANICS IN BOTH WALKING AND RUNNING MODES) AND 2) THE LACK OF ACCESSIBILITY FOR HIGHER ACTIVITY PROSTHESES (THE COST OF THE FOOT WOULD BE COVERED BY INSURANCE).